Manufacturer record

Visa Drugs & Pharmaceuticals Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Visa Drugs & Pharmaceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between July 2020 and July 2020. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

1 record linked to Visa Drugs & Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jul 2020 to Jul 2020

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2020
1
Products affected
Assay
Most common failure
Jul 2020
Latest alert

Flagged batches per year

2020 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ramigal 5 (Ramipril Tablets I.P. 5 mg) VG8034Mfg 2018-10 · Exp 2021-09 AssayAssay CDL KolkataCDSCO lab Jul 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.